ArtFun+
As seen in
ArtFun+
Predictive imaging biomarkers to quantify arterial function
ArtFun+ 1.3.3 is an MDR CE class 2a software as a medical device (SaMD, Class IIa) for medical imaging healthcare professionals to measure advanced cardiovascular imaging biomarkers such as Ascending Aortic Distensibility (AAD) and Aortic Arch Pulse Wave Velocity (AAPWV).
In combination with other risk factors, these biomarkers can improve the understanding of patient’s cardiovascular risk and quantify cardiovascular aging.
We work with leading cardiovascular healthcare professionals, having helped with 77 publications in leading journals. We have also supported the world-reknown MESA trial.
ArtFun+ measure arterial stiffness and flow biomarkers that are commonly recognized as a major risk factor for CV diseases and considered as major predictors of cardiovascular mortality.
ArtFun+ is the most clinically validated & most published technology for measuring arterial stiffness measurement by MRI1,2,3.
How precise are the results?
Imageens has the world’s most clinically validated technology to analyse cardiovascular function by MRI. Our imaging biomarkers are the earliest manifestation of vascular aging, and the strongest predictor of cardiovascular risk for intermediate risk patients.
Imageens has the world’s most clinically validated technology to analyse cardiovascular function by MRI. Our imaging biomarkers are the earliest manifestation of vascular aging, and the strongest predictor of cardiovascular risk for intermediate risk patients.
For ArtFun+ users
The Instructions For Use (IFU) are available for download by clicking on the button below. Users may also request (for free) a paper version of the IFU by sending an email request at support@imageens.com
Footnotes
1) Redheuil A, Yu WC, Wu CO, et al. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010;55(2):319-326. doi:10.1161/HYPERTENSIONAHA.109.141275
2) Redheuil A, Wu CO, Kachenoura N, et al. Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study. J Am Coll Cardiol.
3) Full set of publications available at http://publications.imageens.com/